Dr
Oliver
Chammas

Trainee Patent Attorney

London Office

Telephone. +44(0) 207 776 5100
Email. [email protected]

Experience

Oliver is a Part-Qualified Patent Attorney who joined the London Office in September 2020. Oliver has a PhD in Bio-Nanotechnology and a degree in Medical Biochemistry from the University of Leeds. He has a wide range of experience in prosecution, contentious matters, drafting and freedom-to-operate.

Oliver has worked in private practice in IP for four years in both London and Yorkshire with a number of clients ranging from start-ups and universities to multinational companies.

Oliver's main area of focus is nanoscale biotechnology but he has also had experience with technologies such as biologics, medical devices, medical treatments, diagnostic and analytical methods, antibody technology and second medical use inventions for a range of diseases.

Oliver has experience of patent prosecution in the UK and Europe as well as advising clients as to patent prosecution in foreign jurisdictions including the United States, Japan and China.

Specialisms

  • Cell and gene therapy
  • Diagnostics
  • Gene editing technologies
  • Personalised medicine

Industries

  • Food & drink icon Food & drink
  • Healthcare icon Healthcare
  • Medical devices icon Medical devices
  • Pharmaceuticals icon Pharmaceuticals

Services

  • Patents
  • Portfolio management
  • Searching & competitor monitoring
  • Strategy
  • Transactional IP & commercial support

Qualifications

Trainee


BSC

Medical Biochemistry - University of Leeds

MSC

Integrated PhD & MSc – Molecular Scale Engineering – University of Leeds

PHD

Thesis entitled “Atomic Force Microscopy of DNA-protein Interactions” – University of Leeds

POSTGRADUATE DIPLOMA OR CERTIFICATE

Post-Graduate Certificate in Intellectual Property - Queen Mary University of London

Related News

Event - 7th October 2021

The Business of Science Conference 2021

HGF is sponsoring The Business of Science Conference 2021 on 7th October. Science and the commercialisation of science continues to be fundamental to the economic growth of the UK and …

Event details

IAM Strategy 300 2021

IAM Strategy 300 Global Leaders guide has been published and HGF is delighted to have 4 Partners listed. The guide draws from the worlds of private practice, consulting and other …

Read article
Event - 20th September 2021

German Biotechnology days 2021

HGF’s Partner Dr Markus Zoller is attending and speaking at the German Biotechnology days on 20th September 2021. German Biotechnology days is the go to event in the industry and …

Event details
Event - 9th September 2021

Autonomous Vehicles Expo 2021

HGF is sponsoring the Autonomous Vehicles Expo which is being held on 9th September. Autonomous Vehicles Expo will provide key insights from industry experts on how disruptive technological advances will …

Event details

Decision of the EBoA regarding G1/21

Oral proceedings by videoconference can be enforced by the EPO during the pandemic On 16 July 2021 the EPO’s Enlarged Board of Appeal (EBoA) decided on referral G 1/21 regarding …

Read article
Event - 29th July 2021

HGF and Shiga webinar: Patenting sports and fitness technology in Europe and Japan

HGF in Europe and Shiga in Japan are holding a joint webinar on 29th July 2021. Fitter, faster, stronger – patenting sports and fitness technology in Europe and Japan Sporting …

Event details

IAM Patent 1000 2021

The IAM Patent 1000 – the world’s leading patent professionals 2021 guide has now been published. HGF has 18 European attorneys listed. IAM Patent 1000 is a unique guide that …

Read article
Event - 20th July 2021

WIPR Patents Live webinar: Protecting medical devices in Europe—avoiding common pitfalls

WIPR Patents Live is holding a complimentary session on July 20, at 5pm BST/12pm ET, where HGF Partner & Patent Attorney Kieran Killough will present on ‘Protecting medical devices in …

Event details

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.